pharmaphorum

OCTOBER 1, 2022

With Frontiers Health 2022 mere weeks away, we continue to interview members of the steering committee, gaining insight into what to expect from Milan. Borukhovich has been on such a journey before. Now on his third venture, in fact, he was involved in a start-up doctor rating platform over a decade ago.

Doctors 94

Doctors Doctor FDA Approval Pharmacy 94

pharmaphorum

JANUARY 25, 2023

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.

In-Vivo 98

In-Vivo Clinical Trials Clinical Trials Trials 98

XTalks

JUNE 12, 2023

The company is also focusing on developing its Symplicity Spyral Renal Denervation (RDN) system for achieving target blood pressure level ranges and is conducting a couple of clinical studies with the system. On May 25, 2022, Medtronic and DaVita Inc. billion on R&D, a 5.32 billion in annual revenue in 2022, a 4.20

FDA Approval 98

FDA Approval Production Sales In-Vitro 98